CNN cardia bioplastics limited

Ann: Shareholder Update , page-4

  1. 12,617 Posts.
    lightbulb Created with Sketch. 181
    The SP of a stock doing a SPP usually hovers around the issue price before and after the placement

    And may be there for extended periods of time - dilution is not liked in the market unless a definite return on money given is seen (such as an acquisition etc).

    As jessie pointed out the wording of the SPP document was rather bad as well indicating that if full funds are not the be raised the company would concentrate even more on immediate sales opportunities (just paraphrasing this).

    CNN also has to deal with the fact that massive past dilution and raising of funds has seen no positive return to SH - others can go into why that has been so (management of the past/time lines of development within this part. industry etc) but despite the recent run of positive announcements I would tend to see this as the biggest hurdle.

    The part that may help some of us is asking:

    Has an inflection point been reached to see a "snow ball" effect at long last - market penetration is happening - legislation in various jurisdiction changing to encourage use of products offered - scale of economy becoming more realistic - and large volume contracts being achieved

    The jurisdictions in which CNN is attracting contracts is of interest :

    traditional market places such as US - Eu and AU

    emerging markets: China - Brazil - Malaysia

    and at least from my perception the latter becoming more important for bulk supplies ?


    Frank and Richard seem to think so and from their perspective money is needed to "tool up" for the expected sales - pay for a bigger sales team - and get some "breathing space" (my personal interpretation) so they can forge ahead.


    Then again - the shortfall will be placed - OS investors would be my guess ?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.